A method for at least one of characterizing, diagnosing, and treating an aminobenzoate-related condition for a subject, the method comprising:
- for a set of samples comprising at least one sample associated with the aminobenzoate-related condition:
- determining microorganism nucleic acid sequences, comprising:
- selecting primers for nucleic acid sequences associated with the aminobenzoate-related condition,
- amplifying nucleic acid material from the samples based on the primers;
- and
- determining alignments of the microorganism nucleic acid sequences to reference sequences;
- generating a microbiome functional diversity dataset based on the alignments;
- extracting a set of microbiome functional diversity features from the microbiome functional diversity dataset;
- generating a characterization of the aminobenzoate-related condition based on the set of microbiome functional diversity features;
- determining a therapy for the subject based on the characterization and a subject sample from the subject;
- and
- providing the therapy to the subject, wherein the therapy is operable to modulate microbiome composition to improve a state of the aminobenzoate-related condition.